Eupraxia Pharmaceuticals has secured a $12M loan to advance drug innovations and ensure financial stability through 2025. Learn how this funding fuels their breakthrough treatments.
The $8.2 billion Bunge-Viterra deal is delayed due to pending approvals from China, Canada, and the EU, as regulators review antitrust concerns.
BNP Paribas is acquiring Axa's investment division for €5.5B, creating a major asset management player with €1,500B under management.
Sabio Holdings secures a $10 million credit facility from SLR Digital Finance,replaces Avidbank. This boost supports expansion and enhances financial stability.
